Skip to content

The efficacy and safety of acupuncture and moxibustion for the management of nausea and vomiting in pregnant women: A systematic review and meta-analysis

Hu et al. · Heliyon · 2024

📊Systematic Review and Meta-analysis👥n=2,392 participantsHigh Clinical Impact

Evidence Level

MODERATE
78/ 100
Quality
4/5
Sample
5/5
Replication
4/5
🎯

OBJECTIVE

Assess the efficacy and safety of acupuncture and moxibustion in the treatment of nausea and vomiting in pregnant women

👥

WHO

2,392 pregnant women with nausea and vomiting in early pregnancy (mean 8.76 weeks)

⏱️

DURATION

Studies lasting from 4 days to 4 weeks, most 1-2 weeks

📍

POINTS

PC-6, ST-36, CV-12, SP-4 — points related to strengthening the Spleen and regulating qi (氣)

🔬 Study Design

2392participants
randomization

Acupuncture/Moxibustion

n=1196

Acupuncture, moxibustion, or a combination of both

Control

n=1196

Blank control, conventional therapy, Chinese herbal medicine, or sham acupuncture

⏱️ Duration: 4 days to 4 weeks

📊 Results in numbers

0%

Reduction in ineffective cases vs. control

0%

Efficacy vs. traditional herbs

0%

Efficacy vs. conventional therapy

p > 0.05

No difference in serious adverse events

-18.26 points

Significant reduction on CMS scales

Percentage highlights

72%
Reduction in ineffective cases vs. control
92%
Efficacy vs. traditional herbs
85%
Efficacy vs. conventional therapy

📊 Outcome Comparison

Rate of ineffective cases

Acupuncture/Moxibustion
28
Control
65

Serious adverse events

Acupuncture
8
Control
10
💬 What does this mean for you?

This large study showed that acupuncture and moxibustion are effective and safe treatments for nausea and vomiting during pregnancy. The techniques were more effective than conventional treatments, without increasing risks for mother or baby, offering an important natural alternative for pregnant women.

📝

Article summary

Plain-language narrative summary

Acupuncture and moxibustion in the treatment of nausea and vomiting in pregnant women represent an area of growing medical interest, especially given the need for safe alternatives for pregnant women facing these common symptoms. Nausea and vomiting during pregnancy affect between 50% and 90% of pregnant women, with symptoms ranging from mild to severe that can significantly impact quality of life. In more severe cases, known as hyperemesis gravidarum, these conditions can lead to malnutrition, dehydration, and serious complications for mother and baby. Although antiemetic medications are available, many women and health professionals look for complementary treatments that minimize the risk of side effects to the fetus.

This study aimed to systematically and comprehensively assess the efficacy and safety of acupuncture and moxibustion in controlling these symptoms during pregnancy. The researchers performed a rigorous meta-analysis, a type of study that combines results from multiple investigations to produce more precise and reliable conclusions. To this end, they conducted extensive searches in international and Chinese medical databases, including PubMed, Cochrane, and other specialized sources, covering studies published through July 2023. In the end, they selected 21 randomized controlled clinical trials that met rigorous quality criteria, involving a total of 2,392 pregnant women with mean ages of approximately 28 years and in early pregnancy, around the 8th gestational week.

The results showed that acupuncture and moxibustion were significantly more effective than control groups in reducing nausea and vomiting symptoms. Specifically, when compared with traditional Chinese herbs, conventional therapy, and untreated control groups, acupuncture was consistently superior. Moxibustion also showed promising results when compared with control groups. The researchers assessed efficacy through different symptom scales, including specific scales for traditional Chinese medicine symptoms and standardized questionnaires for quantifying emesis during pregnancy.

Interestingly, when acupuncture was compared with sham acupuncture (where needles are inserted at non-therapeutic points), there was no significant difference, suggesting that the effect may be related both to the specific points and to the act of needle insertion itself.

For patients and health professionals, these findings provide important evidence about a relatively safe therapeutic alternative. The study demonstrated that there were no significant differences in the occurrence of serious adverse events between women who received acupuncture and those in control groups, including risks such as miscarriage, fetal death, or congenital malformations. This suggests that acupuncture can be considered a safe option during pregnancy. However, a higher incidence of minor adverse events related to needles was observed, such as pain, itching, or bruising at application sites, when compared with sham acupuncture.

These effects, while more frequent, are considered mild and temporary. For pregnant women suffering from intense nausea and vomiting and seeking to avoid medications, this therapy may represent a viable alternative, especially when performed by qualified professionals.

Despite the encouraging results, the study has some important limitations that must be considered. Significant heterogeneity was observed among the analyzed studies, that is, methodological differences that may influence the interpretation of results. These differences include variations in the acupuncture points used, treatment duration, and characteristics of the populations studied. In addition, possible publication bias was identified, in which studies with positive results may be more likely to be published than those with negative results.

Most of the included studies were conducted in China, which may limit the applicability of results to other populations. With respect to moxibustion specifically, the number of studies was limited, making it more difficult to draw definitive conclusions about its safety. The researchers emphasize that more long-term clinical studies with standardized methodology are needed to confirm these findings and establish more precise treatment protocols for different patient profiles.

Strengths

  • 1Large sample of 2,392 participants from 21 studies
  • 2Comprehensive analysis including multiple comparisons
  • 3Rigorous safety assessment including serious adverse events
  • 4Inclusion of Chinese-language studies expanding the evidence base
  • 5Use of validated scales for symptom assessment
⚠️

Limitations

  • 1Significant heterogeneity among some studies
  • 2Publication bias detected in some analyses
  • 3Limited number of studies on moxibustion alone
  • 4Variation in the acupuncture points used
  • 5Limited data on adverse events related to moxibustion
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Nausea and vomiting affect between 50% and 90% of pregnant women, and the search for safe alternatives to conventional antiemetics is a real, everyday demand in clinical practice. This meta-analysis with 2,392 participants consolidates evidence that acupuncture and moxibustion offer clinically significant efficacy—a 72% reduction in ineffective cases versus control and an 18.26-point drop on symptom scales—with a safety profile comparable to conventional options for serious outcomes such as miscarriage and malformations. The most immediate application setting is the first trimester, when pharmacologic restriction is more limiting and the patient often refuses medication out of fear of teratogenicity. Point PC-6 (Neiguan) remains the central target in this context, supported by decades of clinical use. Integration with dietary counseling and psychosocial support enhances results, making acupuncture a coherent adjunctive tool in the multidisciplinary management of mild-to-moderate hyperemesis gravidarum.

Notable Findings

The data point that deserves special attention is the superiority of acupuncture over conventional therapy in 85% of cases and over Chinese herbal medicines in 92%, establishing a robust therapeutic advantage in both active comparisons—not only against an inert control. The 18.26-point reduction on traditional Chinese medicine symptom scales represents striking clinical magnitude. Equally relevant is the absence of significant difference in serious adverse events, which validates the method's safety in a vulnerable population. The comparison with sham acupuncture warrants reflection: the absence of statistical difference between real and sham acupuncture does not invalidate the therapeutic effect, but indicates that nonspecific neurophysiologic components—such as the act of insertion and the therapeutic context—participate actively in the antiemetic response, something consistent with what we know about modulation of the vagus nerve and the hypothalamic-pituitary axis in pregnancy emesis.

From My Experience

In my practice, pregnant patients with nausea and vomiting respond with surprising speed to acupuncture—I usually observe noticeable relief by the second or third session, which greatly facilitates adherence at a time when the patient is fragile and skeptical of any intervention. We routinely work with protocols of six to ten sessions during the first trimester, initially spaced twice weekly. The profile that responds best is the otherwise healthy pregnant woman, without comorbidities, with predominantly morning nausea and not requiring hospitalization—severe hyperemesis with hydroelectrolyte disturbance demands inpatient management first. I combine acupuncture with fractionated nutritional counseling and, when necessary, vitamin B6, avoiding higher-risk antiemetics whenever possible. Bilateral PC-6 is non-negotiable in the protocol; ST-36 and CV-12 are added according to the Spleen Qi deficiency pattern many of these patients present. The findings of this meta-analysis are consistent with what we observe routinely: efficacy is real, safety is reassuring, and acupuncture deserves to be considered as a first-line complementary option in these cases.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Heliyon · 2024

DOI: 10.1016/j.heliyon.2024.e24439

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.